Alexandria Real Estate Equities, Inc. (ARE), a prominent actor in life science real estate, ended 2024 with a net diluted income per share of $(0.38) in Q4 and $1.80 for the full year. In terms of Funds from Operations (FFO) per share, diluted and adjusted, the figures were $2.39 for Q4 and $9 for the whole year. Despite certain supply headwinds experienced by the company as indicated by a SWOT analysis, it outperformed competitors amidst a strong trading day. Furthermore, ARE recently announced a public offering of Senior Notes and the acquisition of 7,342 ARE shares by Abel Hall LLC. Its Q4 2024 earnings call transcript has been made available, and Wedbush has reiterated a neutral rating for ARE. The company has also asserted resilient leasing demand in its Q4 FFO. However, significant stock price drops have materialized causing analysts to downgrade ARE to 'Sell'. Despite losses, ARE's stock outperforms competitors and has increased its cash dividend for Q4 and 2024 overall. Following a miss on Q4 earnings, the company unveiled a $500 million common stock repurchase program, setting ARE up for a potential rebound.
Alexandria Real Estate Equities ARE News Analytics from Tue, 25 Jun 2024 07:00:00 GMT to Sat, 01 Feb 2025 14:16:46 GMT -
Rating 1
- Innovation 7
- Information 8
- Rumor -2
